DexCom, Inc. (DXCM)
63.23
+1.01
(+1.62%)
USD |
NASDAQ |
Apr 06, 16:00
63.00
-0.23
(-0.36%)
After-Hours: 19:26
DexCom EPS Diluted (Quarterly) : 0.6761 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Insulet Corp. | 1.441 |
| Abbott Laboratories | 1.030 |
| Intuitive Surgical, Inc. | 2.205 |
| Boston Scientific Corp. | 0.4493 |
| Tandem Diabetes Care, Inc. | -0.0087 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 267.30M |
| Revenue (Quarterly) | 1.260B |
| Total Expenses (Quarterly) | 992.30M |
| Enterprise Value | 23.34B |
| Gross Profit Margin (Quarterly) | 62.93% |
| Profit Margin (Quarterly) | 21.22% |
| Earnings Yield | 3.31% |
| Operating Earnings Yield | 3.56% |
| Normalized Earnings Yield | 3.310 |